Jove
Visualize
Contact Us

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the path forward: advancing global health in a changing world - the 31st Canadian Conference on Global Health in 2025.

Journal of global health·2026
Same author

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same author

Maternal age and pregnancy-related cardiovascular complications.

Nature communications·2026
Same author

A Systematic Review and Meta-Analysis of Psychological Interventions for Reducing Distress During Vaccine Injections.

The Clinical journal of pain·2026
Same author

A Systematic Review and Meta-Analysis of the Effectiveness of Procedural Interventions for Reducing Distress during Vaccine Injections.

The Clinical journal of pain·2026
Same author

A Systematic Review and Meta-Analysis of the Effectiveness of Process Interventions for Reducing Distress during Vaccine Injections.

The Clinical journal of pain·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 21, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Influenza immunization in pregnancy.

Noni E MacDonald1, Laura E Riley, M C Steinhoff

  • 1From the Division Pediatric Infectious Diseases, Dalhousie University, IWK Health Center, Halifax, Nova Scotia, Canada; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts; and Children's Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Obstetrics and Gynecology
|July 23, 2009
PubMed
Summary
This summary is machine-generated.

Vaccinating pregnant women against influenza significantly protects both mothers and infants from illness. This safe and cost-effective intervention reduces influenza-like illness by over 30% and laboratory-proven infections in infants by 63%.

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Area of Science:

  • Public Health
  • Vaccinology
  • Maternal and Child Health

Background:

  • Influenza poses serious risks to pregnant women and infants (0-6 months).
  • Despite availability since the 1960s, only 15% of pregnant women receive the influenza vaccine.
  • Influenza immunization is a critical preventive measure for this vulnerable population.

Purpose of the Study:

  • To evaluate the effectiveness of influenza vaccination in pregnant women.
  • To assess the impact of maternal influenza immunization on infant health outcomes.
  • To highlight the benefits of influenza vaccination for maternal and child health.

Main Methods:

  • A randomized, controlled trial was conducted.
  • Pregnant women were immunized with an inactivated influenza vaccine.
  • Outcomes measured included influenza-like illness and laboratory-proven influenza infections in mothers and infants.

Main Results:

  • Influenza immunization of pregnant women reduced influenza-like illness by over 30% in both mothers and infants.
  • A 63% reduction in laboratory-proven influenza infections was observed in 0- to 6-month-old infants.
  • The intervention demonstrated significant protective effects for both maternal and infant health.

Conclusions:

  • Influenza vaccination during pregnancy is an effective strategy to protect both mothers and infants.
  • Healthcare providers should promote influenza immunization for pregnant women.
  • The vaccine represents a cost-saving intervention against serious influenza complications.